Related Experiment Video
Updated: May 13, 2025

Electroacupuncture Combined with Chinese Medicine Ironing Therapy for Functional Constipation
Published on: July 5, 2024
Efficacy of Home-Based Versus Hospital-Based Disimpaction with Polyethylene Glycol in Pediatric Functional
Srinivas Srinidhi Vadlapudi1, Ujjal Poddar2, Anshu Srivastava1
1Department of Pediatric Gastroenterology, Sanjay Gandhi Postgraduate Institute of Medical Sciences, Raebareli Road, Lucknow, Uttar Pradesh, 226014, India.
Insights
Home-based disimpaction using polyethylene glycol (PEG) is as effective as hospital-based treatment for childhood functional constipation. This approach offers a lower cost, fewer side effects, and greater parental satisfaction.
Area of Science:
- Pediatric Gastroenterology
- Clinical Pharmacology
Background:
- Functional constipation (FC) is a prevalent condition in children, often necessitating disimpaction.
- Polyethylene glycol (PEG) is a common agent for disimpaction, administered either continuously in hospitals or over several days at home.
Purpose of the Study:
- To compare the efficacy, side effects, cost-effectiveness, and parental satisfaction of home-based versus hospital-based PEG disimpaction in children with FC.
Main Methods:
- A randomized controlled trial enrolled 115 children (ages 1-18) diagnosed with FC and fecal impaction.
- Children were randomized to receive PEG disimpaction in a hospital setting or at home.
- Efficacy, side effects, treatment costs, and parental satisfaction (using TSQM) were assessed.
Main Results:
- Successful disimpaction rates were high in both groups (100% hospital-based vs. 94.7% home-based).
- Hospital-based disimpaction was associated with significantly higher rates of vomiting and abdominal distension.
- Home-based disimpaction incurred lower treatment costs and yielded greater parental satisfaction.
Conclusions:
- Home-based PEG disimpaction is a safe and effective alternative to hospital-based treatment for childhood functional constipation.
- The home setting is preferred due to reduced side effects, lower costs, and improved parental satisfaction.
Background/Aims:
Functional constipation (FC) is the most common cause of childhood constipation. Children with FC and fecal impaction need to undergo disimpaction. Polyethylene glycol (PEG) is commonly used for disimpaction either in a hospital setting as a continuous lavage or in a home-based setting over 3-6 days. Randomized control trials comparing the two regimens are not available. The study objectives were to compare the efficacy, side effects, cost-effectiveness, and parental satisfaction of home- and hospital-based disimpaction.
Methods:
Consecutive children attending our hospital (age: 1-18 years) and diagnosed to have FC as per ROME IV and requiring disimpaction were enrolled. Fecal impaction was established clinically (per-abdomen or per-rectal examination) or radiologically (X-ray abdomen- Barr criteria). Stratified block randomization was done. PEG was administered accordingly in a hospital-based or a home-based setting. The side effects, patient acceptability as per the treatment satisfaction questionnaire for medications (TSQM) and cost incurred were noted.
Results:
One hundred and fifteen children (hospital-based [n = 58], home-based [n = 57]) were enrolled. Successful disimpaction in hospital- and home-based disimpaction arm was 100% and 94.7%, respectively (p = 0.12). Vomiting (27.6% vs 5.3%, p = 0.001) and abdominal distension (31% vs 3.5%, p < 0.001) were higher in patients undergoing hospital-based disimpaction. Cost of treatment was higher in hospital-based disimpaction arm (INR 6,250 [2,228-15,585] vs INR 3,355 [850-18,350], p = < 0.001). Parental satisfaction was greater in home-based disimpaction.
Conclusions:
Home-based disimpaction using PEG is as effective as hospital-based disimpaction. Disimpaction in a friendlier home environment, at a lower cost and with fewer side effects makes home-based disimpaction preferable in children.
More Related Videos
Related Concept Videos
Drugs for Treatment of Constipation-Predominant IBS
Drugs Affecting GI Tract Motility: Other Laxatives
Osmotic or saline laxatives, like magnesium hydroxide or milk of...
Drugs for Treatment of Diarrhea-Predominant IBS
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
Drugs Affecting GI Tract Motility: Adsorbents as Antidiarrheal Agents
Adsorbents...
Drugs Affecting GI Tract Motility: Opioids as Antidiarrheal Agents
Opioids, widely used antidiarrheal agents, mitigate diarrhea by slowing down...
Drugs Affecting GI Tract Motility: Bulk-Forming and Stimulant Laxatives
Bulk-forming laxatives, such as psyllium, methylcellulose, and polycarbophil, absorb water in the intestine, increasing stool bulk and promoting bowel movement. This...

